TY - JOUR A1 - Bazihizina, Nadia A1 - Böhm, Jennifer A1 - Messerer, Maxim A1 - Stigloher, Christian A1 - Müller, Heike M. A1 - Cuin, Tracey Ann A1 - Maierhofer, Tobias A1 - Cabot, Joan A1 - Mayer, Klaus F. X. A1 - Fella, Christian A1 - Huang, Shouguang A1 - Al‐Rasheid, Khaled A. S. A1 - Alquraishi, Saleh A1 - Breadmore, Michael A1 - Mancuso, Stefano A1 - Shabala, Sergey A1 - Ache, Peter A1 - Zhang, Heng A1 - Zhu, Jian‐Kang A1 - Hedrich, Rainer A1 - Scherzer, Sönke T1 - Stalk cell polar ion transport provide for bladder‐based salinity tolerance in Chenopodium quinoa JF - New Phytologist N2 - Chenopodium quinoa uses epidermal bladder cells (EBCs) to sequester excess salt. Each EBC complex consists of a leaf epidermal cell, a stalk cell, and the bladder. Under salt stress, sodium (Na\(^{+}\)), chloride (Cl\(^{−}\)), potassium (K\(^{+}\)) and various metabolites are shuttled from the leaf lamina to the bladders. Stalk cells operate as both a selectivity filter and a flux controller. In line with the nature of a transfer cell, advanced transmission electron tomography, electrophysiology, and fluorescent tracer flux studies revealed the stalk cell’s polar organization and bladder‐directed solute flow. RNA sequencing and cluster analysis revealed the gene expression profiles of the stalk cells. Among the stalk cell enriched genes, ion channels and carriers as well as sugar transporters were most pronounced. Based on their electrophysiological fingerprint and thermodynamic considerations, a model for stalk cell transcellular transport was derived. KW - halophyte KW - polar ion transport KW - quinoa KW - salt tolerance KW - stalk cell Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-287222 VL - 235 IS - 5 SP - 1822 EP - 1835 ER - TY - THES A1 - Mayer, Christian T1 - Pfadbildung durch invasive Melanomzellen : Matrixdefekte, Zellfragmente und erleichterte Migration T1 - Release of cell fragments and extracellular matrix remodelling by invading melanoma cells N2 - Die metastatische Invasion von Tumorzellen durch die extrazelluläre Matrix von Geweben erfordert aktive Zellmigration sowie häufig auch den Umbau der Gewebestruktur. In dieser Arbeit sollte mittels metastasierender MV3-Melonomzellen in einem 3D-Kollagenmatrixmodell der migrationsassozierte Matrixumbau zellulär und molekular untersucht werden, insbesondere die physikalische Charakterisierung gebildeter Matrixdefekte, die molekulare Identifi kation freigesetzter Zellbestandteile, sowie den Einfluß pfadbildender Zellen auf die Invasion nachfolgender Zellen. Die Daten zeigen, daß MV3-Melanomzellen während der Migration durch ein 3DKollagengewebe komplette Zellfragmente in zurückbleibenden röhrenförmigen Trassen deponieren. Diese beinhalteten Zytoplasma und teils Zytoskelett umgeben von intakter Zellmembran mit integrierten Oberflächenrezeptoren wie β1-Integrinen, nicht jedoch DNA-Material. Der Durchmesser der Fragmente lag überwiegend bei 1-5 μm, selten über 10 μm, entsprechend unspezifisch freigesetzter Zellfragmente, die während der Migration vom Zellhinterende abgeschilftet werden. In einem Sphäroidmodell ließen sich mehrere Invasionsfronten nachweisen, in denen einer ersten pfadbildenden Zelle entlang neu gebildeter Matrixtrassen weitere Zellen den gleichen präformierten Trassen folgten. Die videomikroskopischen Befunde wurden mittels Konfokalmikroskopie bestätigt. Eine erwartete höhere Migrationsgeschwindigkeit der nachfolgenden Zellen in dem präformierten Pfad bestätigte sich jedoch nicht. Somit führt die Invasion von MV3-Melanomzellen zur Ausbildung strukturell umgebauter Matrixtrassen, die aus Matrixdefekt freigesetzten Zellfragmenten und angrenzender Extrazellulärmatrix bestehen und nachfolgenden Zellen als Leitstruktur für eine orientierte Form der Invasion dienen (Kettenwanderung). Diese Befunde beleuchten die Dynamik von Zellarrangements ähnlich dem Invasionsmuster in histopathologischen Tumorproben. N2 - Tumor cell invasion requires coordinated cell adhesion to an extracellular matrix (ECM) substrate at the leading edge and concomitant detachment at the cell rear. Known detachment mechanisms include the slow sliding of focal contacts, the detachment of adhesion receptors by affinity and avidity regulation, as well as the shedding of adhesion receptors, most notably integrins. In highly invasive melanoma cells migrating within 3D collagen matrices, beta1 integrins and CD44 are released upon retraction of the trailing edge, together with ripping-off complete cell fragments to become deposited along the migration trail of remodeled matrix. Cell fragments reach a size up to 12 microm in diameter, contain cytoplasm and occasionally polymerized actin enclosed by intact cell membrane including surface beta1 integrins, but do not include nuclear material. The release of cell fragments was migration dependent, as impairment of motility by a blocking anti-beta1 integrin antibody also blocked cell particle release. Invasion-associated deposition of cell fragments combines the secretory-type release of vesicles with a physical mechanism of rear retraction and migration efficiency. The deposition of cell fragments may further represent a disregulated detachment strategy with implications for neoplastic cell behavior, such as the paracrine effects on neighbor cells or a negative impact on immune effector cells. KW - Migration KW - Zellfragmente KW - Pfadbildung KW - Matrixumbau KW - Invasion KW - migration KW - invasion KW - cellfragments KW - pathways Y1 - 2006 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-19657 ER - TY - THES A1 - Mayer, Christian T1 - Alternative Keimbildner für transparente, farblose LAS-Glaskeramiken T1 - Nucleating agents for transparent, colorless LAS-glass ceramics N2 - In LAS-Glaskeramiken, die besondere Verbreitung bei Anwendungen als Kochfläche, Brandschutzglas und Bauteil für präzise Optik gefunden haben, werden vorrangig die Keimbildner TiO2 und ZrO2 eingesetzt. Transparente Glaskeramiken weisen jedoch eine mehr oder weniger starke Gelbfärbung auf, die vorrangig aus dem Einsatz von TiO2 zusammen mit unvermeidbaren Fe2O3-Verunreinigungen resultiert. Die Minimierung dieser Gelbfärbung gewinnt zunehmend an Bedeutung. Ziel der vorliegenden Arbeit ist die Prüfung, inwiefern die Verringerung der Eigenfarbe einer transparenten LAS-Glaskeramik durch Ersatz des färbenden Keimbildners TiO2 durch einen weniger färbenden Keimbildner möglich ist, ohne dass das gute Keimbildungsvermögen beeinträchtigt wird. Verschiedene alternative Keimbildner zu TiO2 wurden stets in Kombination mit ZrO2 hinsichtlich Keimbildungsvermögen und Färbung/Transmission untersucht sowie andere Kerneigenschaften im Vergleich zu der Standardkeimbildnerkombination TiO2/ZrO2 diskutiert. Signifikante Vorteile bzgl. Eigenfarbe und Transmission gegenüber dem TiO2/ZrO2-gekeimten Referenzmaterial konnten nur bei der Keimbildnerkombination SnO2/ZrO2 gefunden werden. Die Transmission ist mit 89% statt 87% beim Referenzmaterial höher, die Eigenfarbe ist mit dem Farbort a*/b* = -0,1/+2,3 deutlich näher am Unbuntpunkt als die Referenz a*/b* = -0,6/+5,1, der Yellowness Index reduziert sich von 9,5 auf 4,6. N2 - LAS-glass ceramics, which are widely-used as cooktop panels, fire protection glasses and precise optical devices, are commonly doped with TiO2 and ZrO2 as nucleating agents. Transparent glass ceramics show a more or less intense yellow coloring, which is mainly caused by the use of TiO2 together with unavoidable Fe2O3 contamination. The reduction of yellowness becomes more important. Object of the dissertation is the investigation, whether the yellowness could be reduced by substitution of the coloring TiO2 by a less coloring nucleating agent. Thereby, the nucleating power should be maintained. Several alternative nucleating agents have been tested regarding the nucleating power, coloring/transmission as well as other key properties. The second nucleating agent ZrO2 remained basically unchanged. The results have been compared with the commonly used nucleating agents TiO2 and ZrO2. Significant advantages concerning coloring and transmission have exclusively been found with the combination of SnO2 and ZrO2. The transmission of 89% is higher than reference of 87% and the coloring is definitely lower (a*/b* = -0.1/+2.3 instead of a*/b* = -0.6/+5.1), the yellowness index could be reduced from 9.5 down to 4.6. KW - Glaskeramik KW - Keimbildung KW - Glaskeramik KW - Keimbildner KW - glass ceramic KW - nucleating agents Y1 - 2006 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-19206 ER - TY - JOUR A1 - Rauch, Bernhard A1 - Salzwedel, Annett A1 - Bjarnason-Wehrens, Birna A1 - Albus, Christian A1 - Meng, Karin A1 - Schmid, Jean-Paul A1 - Benzer, Werner A1 - Hackbusch, Matthes A1 - Jensen, Katrin A1 - Schwaab, Bernhard A1 - Altenberger, Johann A1 - Benjamin, Nicola A1 - Bestehorn, Kurt A1 - Bongarth, Christa A1 - Dörr, Gesine A1 - Eichler, Sarah A1 - Einwang, Hans-Peter A1 - Falk, Johannes A1 - Glatz, Johannes A1 - Gielen, Stephan A1 - Grilli, Maurizio A1 - Grünig, Ekkehard A1 - Guha, Manju A1 - Hermann, Matthias A1 - Hoberg, Eike A1 - Höfer, Stefan A1 - Kaemmerer, Harald A1 - Ladwig, Karl-Heinz A1 - Mayer-Berger, Wolfgang A1 - Metzendorf, Maria-Inti A1 - Nebel, Roland A1 - Neidenbach, Rhoia Clara A1 - Niebauer, Josef A1 - Nixdorff, Uwe A1 - Oberhoffer, Renate A1 - Reibis, Rona A1 - Reiss, Nils A1 - Saure, Daniel A1 - Schlitt, Axel A1 - Völler, Heinz A1 - Känel, Roland von A1 - Weinbrenner, Susanne A1 - Westphal, Ronja T1 - Cardiac rehabilitation in German speaking countries of Europe — evidence-based guidelines from Germany, Austria and Switzerland LLKardReha-DACH — Part 1 JF - Journal of Clinical Medicine N2 - Background: Although cardiovascular rehabilitation (CR) is well accepted in general, CR-attendance and delivery still considerably vary between the European countries. Moreover, clinical and prognostic effects of CR are not well established for a variety of cardiovascular diseases. Methods: The guidelines address all aspects of CR including indications, contents and delivery. By processing the guidelines, every step was externally supervised and moderated by independent members of the “Association of the Scientific Medical Societies in Germany” (AWMF). Four meta-analyses were performed to evaluate the prognostic effect of CR after acute coronary syndrome (ACS), after coronary bypass grafting (CABG), in patients with severe chronic systolic heart failure (HFrEF), and to define the effect of psychological interventions during CR. All other indications for CR-delivery were based on a predefined semi-structured literature search and recommendations were established by a formal consenting process including all medical societies involved in guideline generation. Results: Multidisciplinary CR is associated with a significant reduction in all-cause mortality in patients after ACS and after CABG, whereas HFrEF-patients (left ventricular ejection fraction <40%) especially benefit in terms of exercise capacity and health-related quality of life. Patients with other cardiovascular diseases also benefit from CR-participation, but the scientific evidence is less clear. There is increasing evidence that the beneficial effect of CR strongly depends on “treatment intensity” including medical supervision, treatment of cardiovascular risk factors, information and education, and a minimum of individually adapted exercise volume. Additional psychologic interventions should be performed on the basis of individual needs. Conclusions: These guidelines reinforce the substantial benefit of CR in specific clinical indications, but also describe remaining deficits in CR-delivery in clinical practice as well as in CR-science with respect to methodology and presentation. KW - cardiac rehabilitation standards KW - scientific guidelines KW - secondary prevention KW - coronary artery disease KW - chronic heart failure KW - heart valve repair KW - ICD-CRT KW - ventricular assist device KW - heart transplantation KW - peripheral artery disease KW - pulmonary hypertension KW - myocarditis KW - adults with congenital heart disease Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-239709 SN - 2077-0383 VL - 10 IS - 10 ER - TY - JOUR A1 - Eckardt, Jan-Niklas A1 - Stasik, Sebastian A1 - Kramer, Michael A1 - Röllig, Christoph A1 - Krämer, Alwin A1 - Scholl, Sebastian A1 - Hochhaus, Andreas A1 - Crysandt, Martina A1 - Brümmendorf, Tim H. A1 - Naumann, Ralph A1 - Steffen, Björn A1 - Kunzmann, Volker A1 - Einsele, Hermann A1 - Schaich, Markus A1 - Burchert, Andreas A1 - Neubauer, Andreas A1 - Schäfer-Eckart, Kerstin A1 - Schliemann, Christoph A1 - Krause, Stefan W. A1 - Herbst, Regina A1 - Hänel, Mathias A1 - Frickhofen, Norbert A1 - Noppeney, Richard A1 - Kaiser, Ulrich A1 - Baldus, Claudia D. A1 - Kaufmann, Martin A1 - Rácil, Zdenek A1 - Platzbecker, Uwe A1 - Berdel, Wolfgang E. A1 - Mayer, Jiří A1 - Serve, Hubert A1 - Müller-Tidow, Carsten A1 - Ehninger, Gerhard A1 - Stölzel, Friedrich A1 - Kroschinsky, Frank A1 - Schetelig, Johannes A1 - Bornhäuser, Martin A1 - Thiede, Christian A1 - Middeke, Jan Moritz T1 - Loss-of-function mutations of BCOR are an independent marker of adverse outcomes in intensively treated patients with acute myeloid leukemia JF - Cancers N2 - Acute myeloid leukemia (AML) is characterized by recurrent genetic events. The BCL6 corepressor (BCOR) and its homolog, the BCL6 corepressor-like 1 (BCORL1), have been reported to be rare but recurrent mutations in AML. Previously, smaller studies have reported conflicting results regarding impacts on outcomes. Here, we retrospectively analyzed a large cohort of 1529 patients with newly diagnosed and intensively treated AML. BCOR and BCORL1 mutations were found in 71 (4.6%) and 53 patients (3.5%), respectively. Frequently co-mutated genes were DNTM3A, TET2 and RUNX1. Mutated BCORL1 and loss-of-function mutations of BCOR were significantly more common in the ELN2017 intermediate-risk group. Patients harboring loss-of-function mutations of BCOR had a significantly reduced median event-free survival (HR = 1.464 (95%-Confidence Interval (CI): 1.005–2.134), p = 0.047), relapse-free survival (HR = 1.904 (95%-CI: 1.163–3.117), p = 0.01), and trend for reduced overall survival (HR = 1.495 (95%-CI: 0.990–2.258), p = 0.056) in multivariable analysis. Our study establishes a novel role for loss-of-function mutations of BCOR regarding risk stratification in AML, which may influence treatment allocation. KW - acute myeloid leukemia KW - BCOR KW - BCORL1 KW - loss-of-function KW - risk stratification KW - survival Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-236735 SN - 2072-6694 VL - 13 IS - 9 ER - TY - JOUR A1 - Weisschuh, Nicole A1 - Mayer, Anja K. A1 - Strom, Tim M. A1 - Kohl, Susanne A1 - Glöckle, Nicola A1 - Schubach, Max A1 - Andreasson, Sten A1 - Bernd, Antje A1 - Birch, David G. A1 - Hamel, Christian P. A1 - Heckenlively, John R. A1 - Jacobson, Samuel G. A1 - Kamme, Christina A1 - Kellner, Ulrich A1 - Kunstmann, Erdmute A1 - Maffei, Pietro A1 - Reiff, Charlotte M. A1 - Rohrschneider, Klaus A1 - Rosenberg, Thomas A1 - Rudolph, Günther A1 - Vámos, Rita A1 - Varsányi, Balázs A1 - Weleber, Richard G. A1 - Wissinger, Bernd T1 - Mutation Detection in Patients with Retinal Dystrophies Using Targeted Next Generation Sequencing JF - PLoS ONE N2 - Retinal dystrophies (RD) constitute a group of blinding diseases that are characterized by clinical variability and pronounced genetic heterogeneity. The different nonsyndromic and syndromic forms of RD can be attributed to mutations in more than 200 genes. Consequently, next generation sequencing (NGS) technologies are among the most promising approaches to identify mutations in RD. We screened a large cohort of patients comprising 89 independent cases and families with various subforms of RD applying different NGS platforms. While mutation screening in 50 cases was performed using a RD gene capture panel, 47 cases were analyzed using whole exome sequencing. One family was analyzed using whole genome sequencing. A detection rate of 61% was achieved including mutations in 34 known and two novel RD genes. A total of 69 distinct mutations were identified, including 39 novel mutations. Notably, genetic findings in several families were not consistent with the initial clinical diagnosis. Clinical reassessment resulted in refinement of the clinical diagnosis in some of these families and confirmed the broad clinical spectrum associated with mutations in RD genes. KW - mutation detection KW - retinal dystrophies KW - next generation sequencing Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-167398 VL - 11 IS - 1 ER -